This is a non-core endpoint: only basic statistics are computed.
Melanocytic naevi of scalp and neck
CD2_BENIGN_MELANOCYTIC_SCALPNECK_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus (cutis) verticis cranii
Similar endpoints
↥List of similar endpoints to
Melanocytic naevi of scalp and neck
based on the number of shared cases.
Similar with more cases:
- Melanocytic naevi of scalp and neck
- Melanocytic naevi
- Melanocytic naevi
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 902 | 559 | 343 |
| Unadjusted period prevalence (%) | 0.18 | 0.19 | 0.15 |
| Median age at first event (years) | 47.24 | 41.58 | 56.47 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 803
- Matched controls
- 8029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
4670.1
323.0
769
37
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
51.9
289.5
349
117
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
12.5
80.7
152
147
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
356.8
65.5
65
*
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
8.4
56.4
131
181
PJA12
NOMESCO Finland
Sentinel node biopsy
564.2
54.2
53
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.0
54.0
143
240
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
25.0
48.9
69
30
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
48.4
46
*
130
Kela drug reimbursment
Malignant tumour
+∞
41.0
39
*
TQW99
NOMESCO Finland
Other minor procedure on skin
9.8
37.6
78
87
H02AB02
ATC
dexamethasone; systemic
18.5
36.8
57
33
115
Kela drug reimbursment
Breast cancer
+∞
36.7
35
*
2164A
ICD-9 Finland
Benign neoplasm of skin, Scalp and skin of neck[PÄÄN JA KAULAN IHON BEN KASV,NAEVUS PIGMENTOSUS]
+∞
34.6
33
*
A04AA02
ATC
granisetron; systemic, transdermal
171.8
31.9
33
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
31.5
30
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
31.5
30
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
15.2
30.1
50
35
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
7.1
30.0
76
117
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
29.3
28
*
L57.0
ICD-10 Finland
Actinic keratosis
5.4
29.1
91
184
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
26.2
25
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.3
26.0
148
519
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
72.3
24.9
28
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
3.1
23.9
144
524
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
10.3
23.8
47
48
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
5.7
23.2
69
131
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
86.0
22.8
25
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
13.8
21.6
37
28
ZZR00
NOMESCO Finland
Flap of skin
19.5
21.4
32
17
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
8.4
21.2
47
59
WF002
NOMESCO Finland
Radical radiotherapy
+∞
19.9
19
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
19.9
19
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
19.9
19
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
19.9
19
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
18.8
18
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
194.3
18.6
19
*
L02BA01
ATC
tamoxifen; oral
68.2
17.8
20
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
183.9
17.6
18
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
16.7
16
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
16.7
16
*
QAE00
NOMESCO Finland
Excision of loose skin or fold of skin from head and neck
173.4
16.6
17
*
A04AA01
ATC
ondansetron; systemic, rectal
6.8
16.3
41
63
A03FA01
ATC
metoclopramide; systemic, rectal
2.7
16.0
121
502
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
8.0
16.0
36
47
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
15.7
15
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
15.7
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
15.7
15
*
S82
ICPC
Naevus/mole
2.7
15.6
113
457
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
20.5
15.2
22
11
116
Kela drug reimbursment
Prostate cancer
+∞
14.6
14
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
14.6
14
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
81.6
14.6
16
*
9733
FHL
Excision of skin change in operating room or anesthesia
9.1
14.6
30
34
L03AA02
ATC
filgrastim; parenteral
152.7
14.5
15
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
152.7
14.5
15
*
S18
ICPC
Laceration/cut
1.9
14.5
311
2039
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.6
14.3
50
115
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
8.4
13.9
30
37
SPAT1153
SPAT
Removal of sutures
1.9
13.8
237
1425
XQ845
NOMESCO Finland
Dermatoscopy
12.3
13.7
24
20
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
76.5
13.6
15
*
L01BC06
ATC
capecitabine; oral
+∞
13.6
13
*
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
+∞
13.6
13
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
13.6
13
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
13.6
13
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
13.6
13
*
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
7.9
13.5
30
39
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.6
13.5
39
73
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
7.3
13.2
31
44
HAB40
NOMESCO Finland
Wedge excision of mammary gland
19.4
13.0
19
10
XQ848
NOMESCO Finland
Dermatological photography
6.0
12.8
35
61
D23.4
ICD-10 Finland
Benign neoplasm: Skin of scalp and neck
9.9
12.8
25
26
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
12.5
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.5
12
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
12.5
12
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
12.5
12
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
12.5
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
11.5
11
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
121.7
11.5
12
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
9.4
11.0
22
24
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
10.4
10
*
180
Kela drug reimbursment
Interferon alfa
+∞
10.4
10
*
A04AD12
ATC
aprepitant; systemic
+∞
10.4
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.4
10
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
10.4
10
*
JN4BD
NOMESCO Finland
Extensive body CT
3.4
10.4
49
149
JN4CD
NOMESCO Finland
Very extensive body CT
7.5
9.7
22
30
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
11.5
9.6
17
15
ZXC50
NOMESCO Finland
Cryotherapy
6.1
9.6
25
42
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
9.4
9
*
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
9.4
9
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
9.4
9
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
9.4
9
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
9.4
9
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
9.4
185
1148
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
9.4
185
1149
127
Kela drug reimbursment
Transplant complication
6.8
9.2
22
33
L72.1
ICD-10 Finland
Trichilemmal cyst
2.8
8.9
56
209
JN4AD
NOMESCO Finland
Body CT examination
4.5
8.8
30
69
Z94.0
ICD-10 Finland
Kidney transplant status
7.3
8.8
20
28
HA1AA
NOMESCO Finland
X-ray mammography
4.2
8.7
32
79
J01DB01
ATC
cefalexin; oral
1.7
8.5
624
5443
ZXA00
NOMESCO Finland
Right side
1.8
8.4
175
1101
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
8.3
8
*
X76
ICPC
Malignant neoplasm breast female
+∞
8.3
8
*
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
8.3
8
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
8.3
8
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
8.3
8
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
8.3
8
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.1
8.2
21
35
A02BC02
ATC
pantoprazole; systemic
1.5
8.1
445
3588
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
8.1
136
796
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
33.7
8.1
10
*
B01AB05
ATC
enoxaparin; parenteral
1.7
7.9
177
1133
L91.0
ICD-10 Finland
Hypertrophic scar
6.5
7.7
19
30
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.7
264
1898
L04AA01
ATC
[U] ciclosporin; systemic
7.5
7.7
17
23
ZXA10
NOMESCO Finland
Bilateral
1.8
7.6
127
743
XX3DW
NOMESCO Finland
Time consuming IT work
3.0
7.6
43
150
N02BE01
ATC
paracetamol; systemic, rectal
1.6
7.6
630
5559
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.7
7.4
31
87
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
80.8
7.4
8
*
C50.99
ICD-10 Finland
Breast, unspecified
80.8
7.4
8
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
80.8
7.4
8
*
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
13.5
7.4
12
9
C43.49
ICD-10 Finland
Malignant melanoma of the scalp and neck other or unspecified histology
+∞
7.3
7
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
7.3
7
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
Y77
ICPC
Malignant neoplasm prostate
+∞
7.3
7
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
7.3
7
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
7.3
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
ZZA50
NOMESCO Finland
Full thickness skin graft
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
7.3
7
*
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
+∞
7.3
7
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
7.3
7
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.3
7
*
S77
ICPC
Malignant neoplasm of skin
30.3
7.2
9
*
J01FF01
ATC
clindamycin; systemic
1.6
7.1
187
1253
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
7.1
128
768
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
8.9
7.1
14
16
B05DA
ATC
Isotonic solutions
8.9
7.1
14
16
B01AB10
ATC
tinzaparin; parenteral
3.0
6.9
37
126
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
6.8
119
705
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
40.4
6.8
8
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
16.9
6.8
10
6
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
22.7
6.7
9
*
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
8.8
6.6
13
15
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.9
6.6
20
42
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.2
6.5
23
56
137
Kela drug reimbursment
Uraemia requiring dialysis
6.9
6.5
15
22
L02AE02
ATC
leuprorelin; implant, parenteral
6.9
6.5
15
22
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
70.4
6.4
7
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
70.4
6.4
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
70.4
6.4
7
*
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.5
6.3
307
2366
L02BG04
ATC
letrozole; oral
3.8
6.3
25
68
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
6.3
6
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
6.3
6
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
6.3
6
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
6.3
6
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
6.3
6
*
F45.8
ICD-10 Finland
Other somatoform disorders
2.1
6.2
66
326
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
26.9
6.2
8
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
6.2
36
130
ZX120
NOMESCO Finland
Intravenous
2.3
6.1
53
240
D06BB10
ATC
imiquimod; topical
2.6
6.1
40
156
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
367
2543
1.75
14.28
6.0
3.9
36.4
36.5
g/l
0.13
354
2348
431
3147
1.71
13.71
7.6
3.8
10.2
11.0
umol/l
2.06
414
2945
71
273
2.74
13.16
4.1
1.5
2.9
3.8
ug/l
0.35
57
204
486
3869
1.56
9.54
11.0
6.3
4.0
4.2
e9/l
0.82
430
3389
34
105
3.33
9.25
6.2
5.7
547.0
272.9
iu/ml
—
6
12
390
2986
1.54
8.94
9.0
5.4
1.2
1.2
mmol/l
0.10
339
2564
352
2649
1.54
8.66
8.3
5.0
1.2
1.2
mmol/l
0.11
317
2377
76
375
2.12
8.14
1.4
1.6
—
—
—
0
0
598
5104
1.51
7.64
9.7
5.1
76.9
74.3
u/l
1.00
575
4721
138
849
1.74
7.60
4.6
2.9
0.8
0.8
mmol/l
0.59
127
797
801
7357
1.79
7.12
15.9
10.7
21.7
21.4
mg/l
0.11
622
5627
39
153
2.62
7.02
2.9
3.2
—
—
—
0
0
397
3161
1.46
6.98
4.5
3.8
—
—
—
0
0
28
96
2.98
6.47
1.3
1.2
—
—
—
0
0
48
216
2.29
6.47
1.3
1.2
—
—
—
0
0
294
2246
1.46
6.26
4.2
2.9
—
—
—
0
0
100
594
1.77
6.21
2.9
2.2
26.9
35.6
u/l
1.96
85
486
155
1037
1.60
6.14
2.9
2.5
0.7
1.0
e6/l
1.01
105
566
47
217
2.23
5.98
1.3
1.2
—
—
—
0
0
833
7813
1.87
5.91
11.8
8.0
25.1
26.3
u/l
1.17
816
7525
17
45
3.83
5.83
1.5
1.2
59.2
51.2
u/l
0.22
12
31
295
2295
1.42
5.57
3.9
2.7
27.5
32.1
u/l
2.24
286
2190
34
141
2.47
5.51
1.3
1.2
—
—
—
0
0
23
78
3.00
5.44
1.4
1.3
—
—
—
0
0
120
777
1.63
5.42
3.5
2.4
22.6
24.5
%
0.87
105
661
154
1059
1.55
5.39
3.5
2.0
2.4
2.4
mmol/l
0.27
139
906
209
1534
1.47
5.36
2.8
1.9
—
—
—
0
0
568
4970
1.39
5.18
3.3
2.9
42.4
40.0
u/l
0.37
547
4679
262
2018
1.42
5.17
4.5
2.0
2.4
2.4
mmol/l
0.81
231
1721
650
5825
1.41
5.09
4.0
3.9
14.6
14.6
pmol/l
0.19
606
5362
749
6898
1.51
5.02
4.9
4.6
1.8
2.0
mu/l
0.63
710
6402
174
1246
1.49
5.02
3.6
3.5
397.5
343.5
ng/l
0.11
129
865
12
28
4.33
4.83
2.1
2.5
—
—
—
0
0
141
974
1.53
4.82
2.9
2.7
2.1
3.0
e6/l
0.89
87
507
139
958
1.53
4.80
2.0
1.8
—
—
—
0
0
462
3942
1.35
4.76
5.7
4.1
6.4
6.6
mmol/l
1.61
413
3594
533
4650
1.36
4.74
4.5
4.0
18.4
2672.8
e6/l
—
5
62
9
11
8.25
4.57
4.2
5.5
—
—
—
0
0
112
744
1.58
4.55
9.9
5.2
1.1
1.0
mmol/l
0.45
106
687
222
1705
1.40
4.36
3.5
2.8
0.2
0.4
e6/l
2.03
170
1251
29
126
2.34
4.30
1.2
1.1
—
—
—
0
0
109
730
1.56
4.28
4.2
2.4
6.2
6.2
umol/l
0.01
93
616
51
277
1.89
4.27
9.9
8.7
24.1
24.4
mmol/l
0.31
44
255
349
2889
1.34
4.26
2.4
2.3
74.8
75.0
nmol/l
0.06
324
2600
23
91
2.57
4.16
1.8
1.4
—
—
—
0
0
785
7378
1.49
3.98
17.6
12.1
139.6
139.6
mmol/l
0.01
776
7149
135
966
1.47
3.88
3.3
2.2
13.3
14.2
umol/l
0.85
128
887
56
325
1.77
3.82
1.9
1.6
—
—
—
0
0
95
635
1.55
3.78
7.1
7.6
5.0
5.1
kpa
0.90
88
608
95
635
1.55
3.78
7.1
7.6
12.5
12.2
kpa
0.24
88
610
18
66
2.76
3.77
1.8
3.2
2.5
1.4
%
0.29
13
53
785
7404
1.46
3.64
17.9
12.1
3.9
4.0
mmol/l
1.04
774
7165
85
559
1.57
3.63
4.6
3.4
1.8
1.9
mmol/l
0.20
70
448
218
1716
1.36
3.62
2.4
2.1
2.6
2.8
mg/l
0.37
183
1448
94
634
1.54
3.60
7.3
7.6
0.1
1.3
mmol/l
2.48
71
484
101
698
1.50
3.46
8.3
5.7
104.6
104.4
mmol/l
0.21
101
678
31
156
2.02
3.28
1.2
1.2
—
—
—
0
0
6
7
8.62
3.26
1.5
1.1
—
—
—
0
0
17
66
2.61
3.22
8.2
6.9
13.6
11.5
mg/l
0.52
17
61
64
405
1.62
3.22
3.0
1.6
66.5
67.9
g/l
0.78
57
367
678
6282
1.32
3.20
19.1
12.8
13.6
13.5
%
0.86
671
6143
17
67
2.57
3.14
2.5
1.8
5.7
68.0
u/ml
0.48
17
58
112
808
1.44
3.10
8.2
6.1
—
—
—
0
0
20
86
2.36
3.09
1.7
1.5
—
—
—
0
0
720
6747
1.33
3.00
14.6
9.3
85.1
86.6
ml/min/173m2
0.95
585
5341
252
2076
1.30
2.99
3.2
2.3
56.5
56.8
u/l
0.05
237
1911
27
134
2.05
2.98
1.9
1.6
0.3
0.4
nmol/l
0.24
22
122
48
288
1.70
2.97
5.7
3.5
24.2
24.2
mmol/l
0.03
43
262
75
503
1.54
2.97
2.2
2.0
65.9
72.2
ml/min/173m2
0.50
25
192
54
335
1.65
2.96
1.4
1.3
259.1
248.5
miu/ml
0.08
32
159
26
129
2.05
2.88
1.7
1.5
—
—
—
0
0
94
668
1.45
2.83
2.0
1.8
—
—
—
0
0
732
6897
1.33
2.78
3.9
3.7
1.2
1.3
mmol/l
0.79
690
6393
761
7214
1.35
2.74
4.3
4.1
4.7
4.7
mmol/l
0.03
728
6763
93
664
1.45
2.74
2.0
1.7
—
—
—
0
0
744
7033
1.33
2.71
4.4
4.0
5.8
5.8
mmol/l
0.15
707
6472
28
147
1.93
2.68
1.2
1.2
258.8
248.2
u/ml
0.06
13
89
236
1954
1.28
2.66
2.2
2.1
160.5
268.0
u/l
1.22
220
1836
14
55
2.57
2.62
2.9
3.6
—
—
—
0
0
26
134
1.97
2.62
1.7
1.5
—
—
—
0
0
769
7317
1.35
2.57
4.7
4.5
2.8
2.8
mmol/l
0.34
739
6821
45
277
1.66
2.57
1.4
1.4
—
—
—
0
0
593
5466
1.25
2.55
3.4
3.4
—
—
—
0
0
13
50
2.62
2.54
1.2
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
27
144
1.90
2.48
3.5
3.5
0.2
0.4
u/ml
1.98
16
78
163
1301
1.31
2.42
2.8
2.3
4.1
7.6
e6/l
3.20
146
1127
13
52
2.52
2.36
1.3
1.0
—
—
—
0
0
40
247
1.65
2.28
2.3
1.7
—
—
—
0
0
253
2149
1.25
2.27
3.4
3.1
7.6
8.0
mmol/l
0.54
221
1826
310
2695
1.23
2.24
2.0
1.9
96.5
96.2
pmol/l
0.04
154
1411
753
7177
1.30
2.23
4.2
4.0
1.5
1.5
mmol/l
0.48
720
6698
33
195
1.72
2.22
2.5
1.4
—
—
—
0
0
33
195
1.72
2.22
2.5
1.4
6.5
7.4
g/l
3.32
26
151
33
195
1.72
2.22
2.5
1.4
3.5
3.9
g/l
1.10
25
145
5
9
5.58
2.21
1.6
1.7
58.8
96.1
ng/l
—
5
9
10
36
2.80
2.20
2.0
2.2
865.0
971.2
e6/l
—
5
17
12
48
2.52
2.19
2.5
2.0
—
—
—
0
0
41
258
1.62
2.19
1.4
1.4
10.5
8.6
u/l
0.35
34
218
5
10
5.02
2.07
3.6
3.2
1.2
0.3
u/field
—
5
10
18
89
2.04
2.07
1.9
1.3
—
—
—
0
0
177
1458
1.27
2.06
4.3
3.6
21.5
23.8
%
1.33
92
627
7
20
3.52
2.06
1.1
1.0
—
—
—
0
0
7
20
3.52
2.06
1.1
1.0
—
—
—
0
0
15
69
2.19
2.05
1.1
1.1
—
—
—
0
0
28
162
1.75
2.04
1.4
1.4
257.9
325.6
ug/g
0.60
13
92
215
1814
1.24
2.03
5.0
3.7
2.1
1.9
ug/l
0.52
194
1622
31
185
1.70
2.03
2.6
1.4
2.9
3.0
g/l
0.33
25
148
12
51
2.37
1.95
1.1
1.2
—
—
—
0
0
735
7015
1.26
1.94
17.9
11.7
40.1
40.3
%
0.32
569
5334
5
11
4.56
1.94
1.0
1.5
—
—
—
0
0
8
27
2.98
1.94
2.6
1.3
11.6
15.4
ug/l
—
8
27
64
459
1.42
1.90
2.8
2.2
10975.7
3344.6
u/l
0.63
29
200
127
1014
1.29
1.90
3.0
2.6
0.7
0.7
ug/l
0.12
85
630
58
409
1.45
1.88
1.4
1.3
26.7
24.0
iu/l
0.24
50
354
27
159
1.72
1.87
1.4
1.5
—
—
—
0
0
15
72
2.10
1.87
1.9
1.4
—
—
—
0
0
13
59
2.22
1.85
2.1
1.6
—
—
—
0
0
36
230
1.59
1.84
2.1
1.6
—
—
—
0
0
53
369
1.46
1.84
1.7
1.4
—
—
—
0
0
69
505
1.40
1.83
1.3
1.2
275.1
239.3
u/ml
0.12
64
465
35
224
1.59
1.78
1.5
1.6
0.1
0.1
iu/ml
—
6
40
201
1707
1.23
1.78
3.6
2.3
351.2
6284.5
umol/l
5.91
177
1499
13
60
2.18
1.78
1.2
1.4
—
—
—
0
0
22
125
1.78
1.73
1.4
1.2
2.0
4.0
u/ml
0.53
12
43
171
1432
1.24
1.73
1.5
1.5
—
—
—
0
0
90
696
1.33
1.71
1.8
1.9
—
—
—
0
0
188
1593
1.23
1.70
1.9
1.7
1.1
0.9
mg/l
0.49
146
1186
64
470
1.39
1.68
1.3
1.4
—
—
—
0
0
383
3482
1.17
1.59
3.3
2.8
89.1
95.5
ug/l
0.45
369
3246
563
5279
1.18
1.59
4.3
3.8
10.6
10.2
mm/h
0.27
532
4889
6
20
3.01
1.58
2.7
1.2
—
—
—
0
0
391
3567
1.17
1.54
3.6
3.3
0.0
0.0
estimate
0.00
52
638
14
71
1.99
1.54
1.9
1.4
—
—
—
0
0
192
1648
1.21
1.53
3.8
3.5
1.0
1.0
kg/l
1.03
24
229
64
479
1.36
1.52
2.8
2.2
11.0
13.5
nmol/l
1.45
57
425
5
15
3.35
1.52
1.2
1.0
—
—
—
0
0
5
15
3.35
1.52
1.2
1.0
—
—
—
0
0
7
27
2.60
1.51
1.3
1.4
—
—
—
0
0
38
261
1.48
1.46
1.8
1.8
—
—
—
0
0
21
125
1.70
1.44
1.4
1.2
1.8
8.8
u/ml
1.82
14
51
5
16
3.14
1.44
1.0
1.0
—
—
—
0
0
9
39
2.32
1.43
1.2
1.3
—
26.0
—
0
5
9
39
2.32
1.43
1.2
1.1
834.9
1692.7
miu/ml
—
9
39
10
46
2.19
1.40
1.5
1.4
—
—
—
0
0
35
239
1.48
1.39
2.3
1.7
47.5
39.7
nmol/l
0.72
35
229
189
1638
1.19
1.36
3.3
2.9
2674.7
1190.6
ng/l
1.07
169
1359
19
112
1.71
1.36
1.3
1.1
122.9
118.2
%
0.25
19
104
392
3613
1.15
1.29
3.6
3.3
0.0
0.0
estimate
0.80
49
625
5
18
2.79
1.28
1.2
1.2
—
—
—
0
0
5
18
2.79
1.28
1.4
1.9
—
—
—
0
0
5
18
2.79
1.28
1.2
1.3
—
—
—
0
0
5
18
2.79
1.28
1.2
1.2
—
—
—
0
0
678
6501
1.17
1.28
5.4
5.3
38.5
39.0
mmol/mol
0.90
645
6092
58
443
1.33
1.25
2.7
3.1
4.7
4.6
pmol/l
0.05
51
393
19
116
1.65
1.22
1.2
1.4
—
—
—
0
0
19
116
1.65
1.22
1.2
1.4
—
—
—
0
0
386
3567
1.14
1.21
4.9
4.5
0.0
0.0
estimate
0.50
52
641
105
870
1.23
1.20
2.0
2.0
—
—
—
0
0
45
334
1.37
1.17
1.9
1.8
—
—
—
0
0
17
102
1.68
1.17
1.7
1.4
—
—
—
0
0
93
766
1.24
1.13
1.7
1.6
—
—
—
0
0
19
119
1.61
1.12
1.2
1.5
—
—
—
0
0
42
312
1.36
1.10
1.7
1.4
—
—
—
0
0
198
1761
1.16
1.05
1.8
1.6
—
—
—
0
0
9
46
1.97
1.03
2.9
1.7
—
—
—
0
0
9
46
1.97
1.03
1.1
1.2
—
—
—
0
0
9
46
1.97
1.03
1.1
1.2
—
—
—
0
0
9
46
1.97
1.03
1.1
1.2
—
—
—
0
0
12
69
1.75
0.96
1.3
1.1
—
—
—
0
0
20
133
1.52
0.95
1.4
1.2
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
47
366
1.30
0.93
5.5
8.2
23.2
24.4
mmol/l
1.28
42
342
12
70
1.72
0.93
1.3
1.1
—
—
—
0
0
12
71
1.70
0.89
1.1
1.5
—
—
—
0
0
65
532
1.24
0.88
2.8
2.4
9.7
6.8
ug/l
0.33
59
466
10
58
1.73
0.80
1.1
1.1
—
70.4
—
0
7
173
1557
1.14
0.79
1.6
1.5
19.7
21.0
nmol/l
0.55
158
1333
216
1972
1.13
0.79
4.2
4.1
16.1
8.6
mg/mmol
0.90
132
1268
8
48
1.67
0.79
4.0
1.8
—
—
—
0
0
0
26
0.00
0.78
0.0
1.5
—
—
—
0
0
14
90
1.56
0.78
1.4
1.1
94.6
94.7
%
0.00
14
83
85
726
1.19
0.77
22.9
23.0
1.3
1.2
inr
0.27
17
121
7
38
1.85
0.73
1.1
1.0
—
—
—
0
0
18
125
1.45
0.73
1.3
1.1
—
—
—
0
0
5
25
2.01
0.72
1.4
1.5
6.9
8.4
ug/l
—
5
25
5
26
1.93
0.70
1.4
1.2
—
—
—
0
0
5
26
1.93
0.70
1.2
1.1
56.6
97.2
u/l
—
5
19
5
26
1.93
0.70
1.2
1.1
22.8
23.1
u/l
—
5
19
7
42
1.67
0.68
1.0
1.2
—
—
—
0
0
54
449
1.22
0.67
1.5
1.4
—
—
—
0
0
5
28
1.79
0.66
1.6
1.3
208.6
192.7
u/l
—
5
28
11
70
1.58
0.65
1.3
1.1
—
—
—
0
0
5
29
1.73
0.64
5.0
3.3
48.5
29.3
umol/l
—
5
20
51
606
0.83
0.61
1.2
1.2
72.5
136.7
iu/ml
1.39
18
262
8
51
1.57
0.60
1.1
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
8
54
1.49
0.57
1.5
1.7
9.4
12.3
umol/l
—
8
49
110
986
1.13
0.57
1.6
1.7
1.5
1.5
%
0.21
97
882
11
73
1.51
0.56
1.3
1.1
—
—
—
0
0
11
73
1.51
0.56
1.3
1.1
—
—
—
0
0
11
73
1.51
0.56
1.3
1.1
—
—
—
0
0
15
109
1.38
0.51
1.0
1.1
—
—
—
0
0
20
153
1.31
0.50
1.2
1.2
—
6.8
—
0
14
73
644
1.15
0.49
2.6
1.7
355.1
377.2
nmol/l
0.43
67
587
21
163
1.30
0.48
2.0
1.8
160.2
208.1
pmol/l
0.76
21
155
57
499
1.15
0.44
1.2
1.3
—
32.8
—
0
25
199
1869
1.08
0.44
4.4
3.5
0.0
0.0
estimate
0.21
51
632
8
56
1.43
0.42
2.3
1.5
—
—
—
0
0
6
94
0.64
0.42
1.0
1.1
—
—
—
0
0
254
2413
1.07
0.42
3.7
3.3
95.5
51.4
ng/l
0.59
151
1466
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
5
34
1.47
0.40
4.6
3.1
615.8
980.9
u/ml
—
5
34
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
35
1.43
0.39
1.4
1.2
—
—
—
0
0
21
169
1.25
0.39
1.3
1.6
—
—
—
0
0
9
67
1.35
0.38
1.0
1.1
312.3
222.3
mg/l
—
9
60
34
290
1.18
0.37
1.4
1.5
—
—
—
0
0
12
90
1.34
0.36
1.1
1.4
—
—
—
0
0
20
162
1.24
0.35
1.5
2.1
4.6
4.6
umol/l
0.00
14
118
117
1258
0.92
0.35
1.3
1.2
16.4
9.3
u/ml
0.39
47
502
14
109
1.29
0.33
2.5
2.2
17.6
16.8
%
—
8
57
6
90
0.66
0.33
1.0
1.1
—
—
—
0
0
7
55
1.27
0.30
2.9
1.6
0.8
1.0
g/l
—
7
55
175
1838
0.94
0.29
1.7
1.6
1.4
1.4
mmol/l
0.21
159
1554
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
89
830
1.08
0.26
4.4
4.2
30.9
31.8
%
0.40
68
572
14
170
0.82
0.25
1.4
1.4
—
—
—
0
0
5
39
1.28
0.23
1.6
2.4
44.8
49.1
umol/l
—
5
31
13
107
1.22
0.21
1.2
1.6
—
—
—
0
0
286
2781
1.04
0.21
3.8
3.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
134
1394
0.95
0.17
1.4
1.6
56302975.6
30527638.7
pmol/l
0.18
119
1176
41
379
1.09
0.16
4.6
3.7
1.2
2.0
mmol/l
0.59
35
268
11
92
1.20
0.16
1.1
1.3
0.6
0.6
nmol/l
0.19
11
85
6
80
0.75
0.15
1.0
1.1
—
—
—
0
0
28
255
1.10
0.15
1.6
1.5
—
—
—
0
0
13
150
0.86
0.14
1.8
1.7
—
—
—
0
0
7
87
0.80
0.14
1.1
1.0
—
—
—
0
0
32
347
0.92
0.14
1.7
1.9
—
—
—
0
0
47
441
1.07
0.14
1.1
1.0
—
—
—
0
0
117
1130
1.04
0.13
1.7
1.7
1244.3
1159.4
nmol/l
0.37
86
860
141
1450
0.97
0.12
2.6
2.2
—
—
—
0
0
46
436
1.06
0.11
5.5
2.2
1.2
1.2
mmol/l
0.02
40
368
19
173
1.10
0.10
1.1
1.1
—
—
—
0
0
187
1833
1.03
0.09
1.3
1.3
2.7
1.9
u/ml
0.30
47
508
5
46
1.09
0.09
3.0
1.8
0.0
2.8
u/field
—
5
36
5
47
1.06
0.09
3.6
2.2
—
—
—
0
0
67
694
0.96
0.08
1.5
1.5
—
—
—
0
0
20
216
0.92
0.08
1.2
1.3
—
—
—
0
0
39
407
0.96
0.07
1.4
1.5
—
—
—
0
0
36
344
1.05
0.06
1.8
1.8
3.4
3.5
mg/l
0.03
25
231
25
237
1.06
0.05
1.3
2.1
—
—
—
0
0
58
596
0.97
0.05
3.1
2.6
—
—
—
0
0
12
111
1.08
0.04
1.2
1.1
—
—
—
0
0
32
331
0.97
0.03
1.4
1.6
—
—
—
0
0
19
181
1.05
0.03
4.0
4.5
3.9
3.9
mmol/l
0.24
19
168
38
370
1.03
0.03
1.4
1.4
—
—
—
0
0
15
158
0.95
0.02
1.1
1.7
39965.8
10817.0
e6/l
—
9
118
38
371
1.03
0.02
1.4
1.4
—
—
—
0
0
38
371
1.03
0.02
1.4
1.4
—
—
—
0
0
38
372
1.02
0.01
1.4
1.4
—
—
—
0
0
11
116
0.95
0.00
7.4
3.6
4.6
4.1
e9/l
0.21
11
116
16
164
0.98
0.00
2.2
2.1
42.6
116.6
ug/min
—
9
104
30
296
1.01
0.00
1.6
1.7
—
—
—
0
0
21
212
0.99
0.00
1.1
1.1
—
—
—
0
0
132
1322
1.00
0.00
2.3
2.1
—
—
—
0
0
14
137
1.02
0.00
1.1
1.1
—
13.3
—
0
10
7
79
0.89
0.00
1.4
1.5
—
—
—
0
0
7
69
1.01
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
15
150
1.00
0.00
1.2
1.3
—
—
—
0
0
5
57
0.88
0.00
1.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
8.1
—
0
6
5
58
0.86
0.00
3.2
1.2
1.0
1.4
nmol/l
—
5
50
12
120
1.00
0.00
7.2
3.8
58.6
56.7
%
0.30
12
120
131
1310
1.00
0.00
1.3
1.3
40.7
28.6
iu/ml
0.37
37
405
6
61
0.98
0.00
1.2
1.2
—
—
—
0
0
5
56
0.89
0.00
1.2
1.2
—
—
—
0
0
5
56
0.89
0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
6
59
1.02
0.00
1.8
1.3
—
—
—
0
0
6
61
0.98
0.00
1.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_SCALPNECK_EXALLC – Melanocytic naevi of scalp and neck
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).